| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| anti-cd19 car t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
| anti-cd19 car t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hodgkin Disease[MeSHID:D006689] T-Lymphocyte[MeSHID:D013601] |
NA | phase 0 | unknown |
| anti-cd19 car t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hodgkin Disease[MeSHID:D006689] T-Lymphocyte[MeSHID:D013601] |
NA | phase 1/2 | unknown |
| anti-cd19 car t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] T-Lymphocyte[MeSHID:D013601] |
NA | phase 0 | unknown |
| click here to return to the previous page | ||||||||